Expression of Fcε-receptors by human acute myelogenous leukemia (AML) blasts:: studies of high- and low- (CD23) affinity receptor expression and the effects of IgE-mediated receptor ligation on functional AML blast characteristics

被引:3
作者
Bruserud, O [1 ]
Gjertsen, BT [1 ]
Ulvestad, E [1 ]
机构
[1] Univ Bergen, Haukeland Univ Hosp, Gade Inst, Dept Microbiol & Immunol,Div Hematol,Med Dept, N-5021 Bergen, Norway
关键词
acute myelogenous leukemia; CD23; Fc epsilon-receptors; Fc gamma-receptors; IgE;
D O I
10.1016/S0145-2126(01)00165-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute myelogenous leukemia (AML) blasts derived from 20 patients were examined for expression of high- (FcepsilonRI) and low-affinity (FcepsilonRII, CD23) IgE Fcepsilon-receptors. FcepsilonRI expression was not detected for any patient. In contrast, expression of CD23 (at least 15,70 of the blasts stained positive) was detected for 6 out of the 20 patients. Acute lymphoblastic leukemia (ALL) blasts derived from 12 patients did not express CD23 (< 1% positive cells for all patients). The functional effects of FcepsilonR-receptor ligation were also examined for 20 patients, including the five patients with highest CD23 expression (30-55% positive cells) and five patients with verified low CD23 expression (less than or equal to7% positive cells). The presence of I-E during in vitro culture altered the functional characteristics (spontaneous and cytokine- dependent proliferation, colony formation, cytokine secretion, or spontaneous in vitro apoptosis) of AML blasts for a subset of both CD23-positive patients and certain patients with very low CD23 expression. This last observation suggests that FcepsilonR are either expressed at a very low level or receptors are expressed only by a minor cell subset for these patients, We conclude that functional FcepsilonR can be expressed by human AML cells. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:515 / 521
页数:7
相关论文
共 11 条
[1]  
Bruserud O, 2000, STEM CELLS, V18, P343
[2]   New strategies for the treatment of acute myelogenous leukemia: Differentiation induction - Present use and future possibilities [J].
Bruserud, O ;
Gjertsen, BT .
STEM CELLS, 2000, 18 (03) :157-165
[3]   In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media:: Studies of native AML blasts and AML cell lines [J].
Bruserud, O ;
Gjertsen, BT ;
Von Volkman, HL .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (06) :923-932
[4]  
BRUSERUD O, 1995, LEUKEMIA, V9, P1910
[5]  
Campana D, 1999, CYTOMETRY, V38, P139, DOI 10.1002/(SICI)1097-0320(19990815)38:4<139::AID-CYTO1>3.0.CO
[6]  
2-H
[7]   World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997 [J].
Harris, NL ;
Jaffe, ES ;
Diebold, J ;
Flandrin, G ;
Muller-Hermelink, HK ;
Vardiman, J ;
Lister, TA ;
Bloomfield, CD .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) :3835-3849
[8]   The high-affinity IgE receptor (FcεRI):: From physiology to pathology [J].
Kinet, JP .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :931-972
[9]  
Matsuo Y, 1996, Hum Cell, V9, P57
[10]  
Moreau EJ, 1997, AM J CLIN PATHOL, V108, P378